Q2 2016 Holdings
Filed 2016-08-10 | 23 holdings | $97.5K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-08-11) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sciclone Pharmaceuticals Inc | COM | 80862K104 | $14.1K | 1,082,532 | 14.5% |
| Viveve Medical, Inc | COM | 092852W20 | $10.7K | 2,599,711 | 10.9% |
| Aegerion Pharmaceuticals, Inc. (Notes) | NOTE | 00767EAB8 | $9.9K | $17,300,000 | 10.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $9.1K | 811,563 | 9.3% |
| Tobira Therapeutics Inc | COM | 88883P101 | $8.0K | 637,567 | 8.2% |
| Pain Therapeutics Inc | COM | 69562K100 | $6.2K | 2,837,878 | 6.4% |
| QLT Inc. | COM | 746927102 | $5.4K | 3,779,274 | 5.5% |
| Sagent Pharmaceuticals Inc | COM | 786692103 | $5.3K | 356,307 | 5.5% |
| Vericel Corp(VCEL) | COM | 92346J108 | $5.1K | 2,250,000 | 5.2% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $4.9K | 438,000 | 5.0% |
| Recro Pharma Inc | COM | 75629F109 | $3.4K | 428,670 | 3.5% |
| Alere Inc. | COM | 01449J105 | $3.1K | 75,000 | 3.2% |
| Sucampo Pharmaceuticals, Inc. | COM | 864909106 | $2.3K | 213,860 | 2.4% |
| Pacira Pharmaceuticals, Inc.(PCRX) | COM | 695127100 | $1.8K | 52,157 | 1.8% |
| Pernix Therapeutics Holdings | NOTE | 71426V108 | $1.4K | $6,000,000 | 0.2% |
| Pernix Therapeutics HoldingsA | NOTE | 71426VAK4 | $1.4K | $6,000,000 | 1.4% |
| Flamel Technologies SA | COM | 338488109 | $1.4K | 128,005 | 1.4% |
| BioSpecifics Technologies Corp.(BSTC) | COM | 090931106 | $1.2K | 30,000 | 1.2% |
| Enanta Pharmaceuticals, Inc. | COM | 029251M10 | $1.2K | 52,616 | 1.2% |
| Derma Sciences Inc | COM | 249827502 | $1.1K | 283,306 | 1.1% |
| Veracyte, Inc.(VCYT) | COM | 92337F107 | $940 | 186,926 | 1.0% |
| Cumberland Pharmaceuticals, Inc.(CPIX)A | COM | 230770109 | $580 | 128,798 | 0.6% |
| Aviragen Therapeutics, Inc. | COM | 053761102 | $412 | 294,269 | 0.4% |
| Durect Corporation(DRRXEUR) | COM | 266605104 | $98 | 80,160 | 0.1% |